|
22.03.2012
The US firm Myriad specialises in the study of genetic cancer risk. The company recently opened a new European laboratory in Martinsried.
|
|
03.02.2012
The courage to enter new territory seems to be paying off in the biotech industry. This is well demonstrated by the example of Micromet. The company has just been acquired for more than a billion dollars by the world's largest biotech corporation, Amgen. A selling-off is not in the pipeline.
|
|
01.02.2012
German biogas companies are world leaders in their field. Now they are taking the energy revolution abroad – including to Canada. This past autumn, a number of companies set out to explore the country, where such terms as bioenergy and biorefineries are beginning to enter daily life.
|
|
17.01.2012
Biotechnology companies are heading into 2012 with mixed feelings about the future. This is one conclusion of the latest branch survey from industry association BIO Deutschland and the magazine |transkript. One reason for this outlook is the current timidity of investors.
|
|
29.11.2011
Assisted by antibodies, scientists have developed a method that can make breast tumours highly visible during surgery, making the surgery more gentle and effective.
|
|
28.11.2011
Plastics made from renewable raw materials are finding ever-wider application. Once just a niche product, now larger premium brand manufacturers are donning the green mantle. In late November, a major conference was dedicated to issues of sustainability and product recycling.
|
|
24.11.2011
The Medica in Düsseldorf is a mega event for healthcare providers, medical device manufacturers, and laboratory suppliers. Biotechnology has always also been a part of the health fair; this time bio-implants and high-security mobile labs were big topics.
|
|
11.11.2011
Following its industry potato Amflora, BASF is now applying for the first European approval for a genetically modified potato intended for the dinner plate. Critics are arguing that there are alternatives to biotech tubers.
|
|
04.11.2011
The 2nd High-Tech Start-Up Fund has 288.5 million of capital to once again lend support to technology-driven start-ups. This time, companies from the Life Sciences are on also board as investors.
|
|
30.10.2011
The prospects are good for industrial biotechnology in Germany. A new study argues for the expansion of ethanol production and the reintroduction of production for previously discontinued sectors.
|
